Sandoz SpA - Company Review
Sandoz SpA - Company ReviewSummary
Sandoz SpA (Sandoz), a subsidiary of Novartis AG is a healthcare products provider that offers generic drug products. The company develops and manufactures API products. Its products include generic drug equivalents, oncology and hospital injecting, biosimilars; active principles, biotechnology and lifeminine products. Sandoz’s products are used in anti-infectives for systemic use, cardiovascular system, central nervous system, gastrointestinal tract and metabolism; antineoplastic and immuno-modulating agents; respiratory system and blood and blood-forming organs. The company also provides technologies, formulations and avant-garde devices, orodispersible film, transdermal patches, lyophilized products, plant and inhalers. It has its presence in Algeria, Austria, Brazil, China, Denmark, Finland, France, Germany, Hungary, Japan, Sweden, Belgium, Canada, South Korea, the Netherlands, the UK and the US, among others. Sandoz is headquartered in Origgio, Italy.
This comprehensive company report of Sandoz SpA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.